Original Article

First-Year Outcomes of Cataract Surgery Combined with Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
  • Sabahattin Sül
  • Aylin Karalezli
  • Müjdat Karabulut
Turk J Ophthalmol 2019; 49: 15-19 DOI: 10.4274/tjo.galenos.2018.76429 PMID:30829020
Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
  • Umut Karaca
  • Ali Hakan Durukan
  • Fazil Cüneyt Erdurman
  • Güngör Sobacı
  • Mehmet Zeki Bayraktar
Turk J Ophthalmol 2012; 42: 25-29 DOI: 10.4274/tjo.42.46036
Direct Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure
  • Şeyda Yıldırım
  • Cezmi Akkın
  • Zafer Öztaş
  • Serhad Nalçacı
  • Filiz Afrashi
  • Jale Menteş
Turk J Ophthalmol 2018; 48: 27-32 DOI: 10.4274/tjo.44370 PMID:29576895
Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration
  • Remzi Avcı
  • Ayşegül Mavi Yıldız
  • Esat Çınar
  • Sami Yılmaz
  • Cem Küçükerdönmez
  • Fatma Duriye Akalp
  • Emre Avcı
Turk J Ophthalmol 2021; 51: 38-44 DOI: 10.4274/tjo.galenos.2020.72540 PMID:33631914
Dry Eye and Meibomian Gland Dysfunction in Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Injections
  • Pelin Kıyat
  • Melis Palamar
  • Serhad Nalçacı
  • Cezmi Akkın
Turk J Ophthalmol 2022; 52: 157-161 DOI: 10.4274/tjo.galenos.2021.66168 PMID:35769012
Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration
  • Pelin Kıyat
  • Jale Menteş
  • Serhad Nalçacı
  • Filiz Afrashi
  • Mine Barış
Turk J Ophthalmol 2021; 51: 161-168 DOI: 10.4274/tjo.galenos.2020.52460 PMID:34187151
Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1
  • Abdullah Özkaya
  • Levent Karabaş
  • Cengiz Alagöz
  • Zeynep Alkın
  • Özgür Artunay
  • Selim Bölükbaşı
  • Gökhan Demir
  • Mehmet Demir
  • Ali Demircan
  • Burak Erden
  • Gürkan Erdoğan
  • Mehmet Erdoğan
  • Erdem Eriş
  • Havva Kaldırım
  • İsmail Umut Onur
  • Özen Osmanbaşoğlu
  • Sezin Özdoğan Erkul
  • Mine Öztürk
  • İrfan Perente
  • Kübra Sarıcı
  • Nihat Sayın
  • Dilek Yaşa
  • İhsan Yılmaz
  • Zeynep Yılmazabdurrahmanoğlu
Turk J Ophthalmol 2018; 48: 232-237 DOI: 10.4274/tjo.31697 PMID:30405944
Risk-based Algorithm-guided Treatment Protocol for the Management of Neovascular Age-related Macular Degeneration
  • Murat Karaçorlu
  • Mümin Hocaoğlu
  • Serra Arf
  • M. Giray Ersöz
  • Işıl Sayman Muslubaş
Turk J Ophthalmol 2019; 49: 258-269 DOI: 10.4274/tjo.galenos.2019.26235 PMID:31650792
Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration
  • Mine Esen Barış
  • Jale Menteş
  • Filiz Afrashi
  • Serhad Nalçaçı
  • Cezmi Akkın
Turk J Ophthalmol 2020; 50: 275-282 DOI: 10.4274/tjo.galenos.2020.38488 PMID:33342194
Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment
  • Jale Menteş
  • Mine Esen Barış
Turk J Ophthalmol 2022; 52: 338-341 DOI: 10.4274/tjo.galenos.2021.16578 PMID:36317811